Pharmacological Management of Type 2 Diabetes Mellitus: Rationale for Rational Use of Insulin

Chan, Jean L.; Abrahamson, Martin J.
April 2003
Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p459
Academic Journal
Investigates the use of insulin in the pharmacological management of type-2 diabetes mellitus (DM2). Pathophysiology and natural history of DM2; Diabetes treatment goals; Oral antihyperglycemic agents; Combination therapy options for DM2; Comparison of human insulins and insulin analogues.


Related Articles

  • Efficacy of once-daily insulin.  // Critical Care Alert;Dec2009 Pharmacology Watch, p1 

    The article presents a study which aims to determine the efficacy of simple once-a-day insulin regimen for type 2 diabetes in England.

  • Repaglinide Versus Metformin in Combination With Bedtime NPH Insulin in Patients With Type 2 Diabetes Established on Insulin/Metformin Combination Therapy. Furlong, Niall J.; Hulme, Shirley A.; O'Brien, Sarah V.; Hardy, Kevin J. // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1685 

    OBJECTIVE -- To compare the effect on glycemic control and weight gain of repaglinide versus metformin combined with bedtime NPH insulin in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS -- A total of 80 subjects treated with 850 or 1,000 mg t.i.d, metformin combined with bedtime NPH...

  • Comparison of Insulin Monotherapy and Combination Therapy With Insulin and Metformin or Insulin and Troglitazone in Type 2 Diabetes. Strowig, Suzanne M.; Avil├ęS-Santa, M. Larissa; Raskin, Philip // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1691 

    OBJECTIVE -- To evaluate the safety and efficacy of treatment with insulin alone, insulin plus metformin, or insulin plus troglitazone in individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS -- A total of 88 type 2 diabetic subjects using insulin monotherapy (baseline HbA[sub1c] 8.7%)...

  • Limitations of HbA[sub1c] in diabetes control.  // Pulse;3/24/2003, Vol. 63 Issue 12, p88 

    Discusses the limitations of the HbA[sub 1c] in aiding the treatment of type 2 diabetes. Method of monitoring the effectiveness of therapy in diabetes; Clinical advantages of measuring fructosamine level.

  • New diabetes treatments may be on horizon.  // Diabetes in the News;Nov/Dec94, Vol. 13 Issue 6, p3 

    Reports on studies regarding new therapies for type II diabetes. Food and Drug Administration's (FDA) pending approval of an oral agent called metformin; Studies on thiazoles and vanadates; Mechanism of action of tolrestat; Use of combination drug approach in diabetes-related impotence; Use of...

  • Exenatide LAR: A sustained-release formulation of exenatide for the treatment of type 2 diabetes.  // Formulary;Feb2010, Vol. 45 Issue 2, p34 

    An abstract of the article "Exenatide LAR: A sustained-release formulation of exenatide for the treatment of type 2 diabetes," by Ashley Krause and Jennifer Kirwin is presented.

  • Managing Obesity as First-Line Therapy for Diabetes Mellitus. Kelley, David E. // Nutrition in Clinical Care;Jan/Feb98 Supplement 1, Vol. 1 Issue 1, p38 

    Focuses on the management of obesity for the treatment of type 2 diabetes mellitus in the United States. Improvement of weight loss in obese patients; Impact of weight loss on the clinical efficacy of concominant pharmacologic therapy; Reduction of skeletal muscles insulin resistance.

  • Newer, controlled-release glipizide is superior to its conventional form.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p53 

    Presents an abstract of the article `Comparative Efficacy of a Once-daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM,' by M. Berelowitz, C. Fischette et al dated December 1994.

  • New hypoglycemic should help physicians `do a better job'.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p28 

    Reports on the approval of the drug glimepiride for the treatment of noninsulin-dependent diabetes by 1995. Oral hypoglycemics as a tool for caring for noninsulin-dependent diabetes; Recommended dosage for glimepiride; Study presented at the Ameri can Diabetes Association Conference held in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics